Patent Assignment
Reel/Frame 038592/0044
Corrective Assignment to Correct the Correspondence Data Previously Recorded on Reel 037155 Frame 0732. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2016-05-02
Pages: 29
Assignor
BAXALTA GMBH
Executed: 2015-08-19
Assignee
NANOTHERAPEUTICS, INC.
13859 PROGRESS BLVD., SUITE 300, ALACHUA, FLORIDA, 32615
Covered Properties
(41)
Method for Controlling the Infectivity of Viruses
Patent:
5,756,341 →
Application:
08/483,522 →
Method for Producing Viruses and Vaccines in Serum-Free Culture
Patent:
5,753,489 →
Application:
08/487,046 →
Method for Producing Influenza Virus & Vaccine
Patent:
5,698,433 →
Application:
08/684,729 →
Production of Orthomyxoviruses in Monkey Kidney Cells Using Protein-Free Media
Patent:
6,146,873 →
Application:
08/849,716 →
Method of Inactivating Lipid-Enveloped Viruses
Patent:
6,136,321 →
Application:
09/021,146 →
Inactivated Influenza Virus Vaccine for Nasal or Oral Application
Patent:
6,635,246 →
Application:
09/913,400 →
Method of Isolation and Purification of Trypsin from Pronase Protease and Use Thereof
Enveloped Virus Vaccine and Method for Production
Method for Large Scale Production of Virus Antigen
Inactivated Influenza Virus Vaccine for Nasal or Oral Application
Use of Purified Streptomyces Griseus Trypsin for Production of a Biomass of Cells and Viral Propagation
Large Scale Productions of Virus Antigen
Inactivation of a pathogen in a sample by a treatment with formalin and UV light
Enveloped virus vaccine and method for production
Application:
11/657,848 →
Publication:
US 2007/0141617
Method of Isolation and Purification of Trypsin from Pronase Protease and Use Thereof
Two-Step Temperature Profile for the Propagation of Viruses
Method for Producing Viral Vaccines
Vaccine Formulations and Uses Thereof
Method for influenza virus protection
Application:
12/309,135 →
Publication:
US 2010/0158944
Method for Producing Continuous Cell Lines
Medium Supplement for Virus Production
METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES
Novel Method for Generation of Rna Virus
Production of Viral Vaccine
Method of Isolation and Purification of Trypsin from Pronase Protease and Use Thereof
Linear Expression Constructs for Production of Influenza Virus Particles
Application:
12/666,459 →
Publication:
US 2010/0129399
Modified Influenza Virus
METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES
Novel Method for Generation of Rna Virus
High Growth Reassortant Influenza a Virus
Vaccine Formulations and Uses Thereof
Novel Influenza Virus
Methods for Isolating and Quantifying Antigen from Vaccines
Method for Producing Viral Vaccines
Application:
13/928,094 →
Publication:
US 2013/0287811
Recombinant Viral Vectors and Methods for Inducing a Heterosubtypic Immune Response to Influenza a Viruses
Replication Deficient Influenza Virus for the Expression of Heterologous Sequences
Enveloped Virus Vaccine and Method for Production
Application:
14/264,925 →
Publication:
US 2016/0199478
METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES
Application:
14/468,131 →
Publication:
US 2014/0377308
Method for Producing Continuous Cell Lines
Method for producing continuous cell lines
Application:
61/067,174 →
Recombinant Viral Vectors and Methods for Inducing a Heterosubtypic Immune Response to Influenza a Viruses
Application:
61/438,024 →
Related Assignments
(11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 18, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH
Reel/Frame 036388/0729 →
Assignment of Assignor's Interest
Aug 18, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH
Reel/Frame 036388/0070 →
Assignment of Assignor's Interest
Aug 28, 2015
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH
Reel/Frame 036502/0752 →
Assignment of Assignor's Interest
Nov 24, 2015
From: BAXALTA GMBH
To: NANOTHERAPEUTICS, INC.
Reel/Frame 037155/0732 →
Security Interest
May 1, 2018
From: OLOGY BIOSERVICES, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 046050/0305 →
Change of Name
Jan 23, 2019
From: NANOTHERAPEUTICS, INC.
To: OLOGY BIOSERVICES, INC.
Reel/Frame 048117/0275 →
Change of Name
Jan 23, 2019
From: NANOTHERAPEUTICS, INC.
To: OLOGY BIOSERVICES, INC.
Reel/Frame 049518/0666 →
Security Interest Supplement
Jun 12, 2020
From: OLOGY BIOSERVICES, INC.; MAMO ADM, LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 052927/0061 →
Release of Security Interest
Aug 20, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: OLOGY BIOSERVICES, INC.; NANO ADM, LLC
Reel/Frame 053561/0070 →
Change of Name
Sep 8, 2022
From: OLOGY BIOSERVICES, INC.
To: RESILIENCE GOVERNMENT SERVICES, INC.
Reel/Frame 061399/0903 →
Change of Name
Nov 20, 2025
From: RESILIENCE GOVERNMENT SERVICES, INC,
To: ALACHUA GOVERNMENT SERVICES, INC.
Reel/Frame 073279/0021 →